Is Narmada water being made to flow in Sabarmati not supplied to city of Ahmedabad? This has furthered the idea of river...
I have been selling glass for commercial buildings talking about light, thermal/solar heat gain etc.etc..but I...
Dear Saxena ji,
Thank you for inquiry.
West facing windows can be a big source of heat, first measure which you...
indias Universal Immunisation Programme may suffer yet another blow. The centre has asked all state governments to stop use of measles vaccine manufactured by Indian Immunological Limited, until further orders, after four infants died following inoculation with the drug.
The children died in the last week of April soon after they were administered the measles vaccine in Tamil Nadus Thiruvallur district. Soon after the incident, the Union minister for health and family welfare, Anbumani Ramadoss, set up a high-level committee to probe the deaths.
Preliminary investigations linked the deaths to human error. As a precautionary measure, the Tamil Nadu government has ordered that vaccination be carried out only at primary health centres under trained supervision.
Indian Immunological Limited (iil), a subsidiary of the National Development Board, had supplied the measles vaccine for the national immunization programme for the first time.
It was asked to provide 9 million doses, which were supplied to Maharashtra, Rajasthan, Assam, Gujarat, Uttar Pradesh, Chhattisgarh, Jharkhand, Madhya Pradesh, Bihar and Tamil Nadu.
The government has now asked iil to stop further supply of the vaccine to the states and has sent samples to the Central Government Laboratory in Kasauli for testing; the laboratory had tested the vaccine before releasing it to the states as part of routine.
Of late, the government has also revoked manufacturing licences of three other public sector vaccine manufacturing unitsCentral Research Institute in Kasauli, Pasteur Institute of India in Coonoor and BCG Vaccine Laboratory in Chennaifor not meeting whos good manufacturing standards.
Experts feel closure of these public sector units could put pressure on the national immunization programme, which gets most of the vaccines from these units. Since importing vaccines will increase the cost of the programme, in the long run, this could affect Indias self sufficiency in immunisation, says S K Mittal, head of the department of paediatrics, Max Hospital, Delhi.
Measles, a vaccine-preventable disease, continues to be a leading cause of deaths in children in India. According to National Family Health Survey, 2005-2006, less than 60 per cent of the children are vaccinated for this viral disease.